| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0095 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0022 | 1 |